EP2250201
MEMBRANE TRANSPORTER NAPI2B (SLC34A2) EPITOPE FOR ANTIBODY THERAPY, ANTIBODIES DIRECTED THERETO, AND TARGET FOR CANCER THERAPY
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
29.1.2009EP published:
30.4.2014EP application number:
09706983.5
EPO information:
European Patent Register
Max expiry date:
28.1.2029
Title:
MEMBRANE TRANSPORTER NAPI2B (SLC34A2) EPITOPE FOR ANTIBODY THERAPY, ANTIBODIES DIRECTED THERETO, AND TARGET FOR CANCER THERAPY
Timeline
Today
29.1.2009EP application
30.4.2014EP Publication
Owner
Name:
Ludwig Institute for Cancer Research Ltd.Address:
666 Third Avenue 28th Floor, 10017, New York, NY, US
Name:
Institute Of Molecular Biology And Genetics National Academy of Sciences of UkraineAddress:
150 Zabolotnogo str., 03143, Kyiv, UA
Name:
Sloan-kettering Institute For Cancer ResearchAddress:
1275 York Avenue, 10065, New York, NY, US
Inventor
Name:
RITTER, GerdAddress:
New York, NY, US
Name:
YIN, BeatriceAddress:
New York, NY, US
Name:
MURRAY, AnneAddress:
New York, NY, US
Name:
MARK, GeorgeAddress:
New York, NY, US
Name:
OLD, LloydAddress:
New York, NY, US
Name:
LLOYD, KennethAddress:
New York, NY, US
Name:
SOUCHELNYTSKIY, SerhiyAddress:
Stockholm, SE
Name:
GOUT, IvanAddress:
London WC1E 6BT, GB
Name:
FILONENKO, ViktorovichAddress:
Kyiv, UA
Name:
KIYAMOVA, RamziyaAddress:
Kyiv, UA
Priority
Number:
62901 PDate:
29.1.2008Country:
US
Classification
Categories:
C07K 16/30, C07K 14/705, C07K 16/28, A61K 39/395, A61P 35/00, A61K 38/17, A61K 38/04